{"AllianceGenome": "11284", "HGNC": "11284", "MIM": "184753", "_id": "6715", "_version": 1, "accession": {"genomic": ["AC010366.6", "AF073301.1", "AF073302.1", "AF073303.1", "AF073304.1", "AH003000.2", "AY341029.1", "CH471102.2", "CP068273.2", "NC_000005.10", "NC_060929.1"], "protein": ["AAA35490.1", "AAA60995.1", "AAC26862.1", "AAC26863.1", "AAC26864.1", "AAC26865.1", "AAC28620.1", "AAF14869.1", "AAH07033.1", "AAH08673.1", "AAP35480.1", "AAP88935.1", "BAG35898.1", "BAH12524.1", "BAH12598.1", "BAH14367.1", "EAX08103.1", "EAX08104.1", "NP_001038.1", "NP_001311251.1", "NP_001311252.1", "P18405.1"], "rna": ["AF052126.1", "AF113128.1", "AK297208.1", "AK297511.1", "AK313070.1", "AK315996.1", "BC006373.2", "BC007033.1", "BC008673.2", "BT006834.1", "CV570670.1", "DA170063.1", "DC350933.1", "M32313.1", "NM_001047.4", "NM_001324322.2", "NM_001324323.2", "NR_136739.2"], "translation": [{"protein": "BAH14367.1", "rna": "AK315996.1"}, {"protein": "NP_001038.1", "rna": "NM_001047.4"}, {"protein": "NP_001311252.1", "rna": "NM_001324323.2"}, {"protein": "AAH08673.1", "rna": "BC008673.2"}, {"protein": "BAG35898.1", "rna": "AK313070.1"}, {"protein": "BAH12524.1", "rna": "AK297208.1"}, {"protein": "AAP35480.1", "rna": "BT006834.1"}, {"protein": "AAA35490.1", "rna": "M32313.1"}, {"protein": "BAH12598.1", "rna": "AK297511.1"}, {"protein": "AAF14869.1", "rna": "AF113128.1"}, {"protein": "AAC28620.1", "rna": "AF052126.1"}, {"protein": "AAH07033.1", "rna": "BC007033.1"}, {"protein": "NP_001311251.1", "rna": "NM_001324322.2"}]}, "alias": "S5AR 1", "ec": "1.3.1.22", "ensembl": {"gene": "ENSG00000145545", "protein": ["ENSP00000274192", "ENSP00000421342", "ENSP00000425330", "ENSP00000518753"], "transcript": ["ENST00000274192", "ENST00000504286", "ENST00000510531", "ENST00000513117"], "translation": [{"protein": "ENSP00000425330", "rna": "ENST00000510531"}, {"protein": "ENSP00000421342", "rna": "ENST00000513117"}, {"protein": "ENSP00000274192", "rna": "ENST00000274192"}, {"protein": "ENSP00000518753", "rna": "ENST00000504286"}], "type_of_gene": "protein_coding"}, "entrezgene": "6715", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.29180019749, "exp_mis": 114.347405592, "exp_syn": 59.3873455841, "lof_z": 0.094825542847066, "mis_z": 1.57107592212003, "mu_lof": 7.02499543252e-07, "mu_mis": 1.13007729098e-05, "mu_syn": 5.84162510696e-06, "n_lof": 9.0, "n_mis": 80.0, "n_syn": 45.0, "p_li": 1.81750169865493e-06, "p_null": 0.747297393029326, "p_rec": 0.252700789468975, "syn_z": 1.15739956076102}, "bp": 780, "cds_end": 6668381, "cds_start": 6633689, "n_exons": 5, "nonpsych": {"exp_lof": 8.31256546524, "exp_mis": 103.398028842, "exp_syn": 53.6538670117, "lof_z": 0.106469549354783, "mis_z": 1.60702927520958, "mu_lof": 7.02499543252e-07, "mu_mis": 1.13007729098e-05, "mu_syn": 5.84162510696e-06, "n_lof": 8.0, "n_mis": 71.0, "n_syn": 37.0, "p_li": 8.93621562600067e-06, "p_null": 0.699232344134214, "p_rec": 0.30075871965016, "syn_z": 1.431456475008}, "nontcga": {"exp_lof": 8.53896155455, "exp_mis": 105.190125724, "exp_syn": 54.6268640845, "lof_z": 0.519525001059784, "mis_z": 1.56366961108514, "mu_lof": 7.02499543252e-07, "mu_mis": 1.13007729098e-05, "mu_syn": 5.84162510696e-06, "n_lof": 7.0, "n_mis": 73.0, "n_syn": 44.0, "p_li": 8.07710145802808e-05, "p_null": 0.471978033145966, "p_rec": 0.527941195839454, "syn_z": 0.91038303462987}, "transcript": "ENST00000274192.5"}, "exons": [{"cdsend": 6668268, "cdsstart": 6633576, "chr": "5", "position": [[6633439, 6633869], [6651841, 6652008], [6656077, 6656179], [6662815, 6662966], [6668201, 6674383]], "strand": 1, "transcript": "NM_001047", "txend": 6674383, "txstart": 6633439}, {"cdsend": 6668268, "cdsstart": 6633550, "chr": "5", "position": [[6633439, 6633869], [6656077, 6656179], [6662815, 6662966], [6668201, 6674383]], "strand": 1, "transcript": "NM_001324322", "txend": 6674383, "txstart": 6633439}, {"cdsend": 6668268, "cdsstart": 6645235, "chr": "5", "position": [[6633439, 6633869], [6644807, 6645309], [6651841, 6652008], [6656077, 6656179], [6662815, 6662966], [6668201, 6674383]], "strand": 1, "transcript": "NM_001324323", "txend": 6674383, "txstart": 6633439}, {"cdsend": 6674383, "cdsstart": 6674383, "chr": "5", "position": [[6633439, 6633869], [6651841, 6652008], [6653446, 6653636], [6656077, 6656179], [6662815, 6662966], [6668201, 6674383]], "strand": 1, "transcript": "NR_136739", "txend": 6674383, "txstart": 6633439}], "exons_hg19": [{"cdsend": 6668381, "cdsstart": 6633689, "chr": "5", "position": [[6633552, 6633982], [6651954, 6652121], [6656190, 6656292], [6662928, 6663079], [6668314, 6674496]], "strand": 1, "transcript": "NM_001047", "txend": 6674496, "txstart": 6633552}, {"cdsend": 6668381, "cdsstart": 6633663, "chr": "5", "position": [[6633552, 6633982], [6656190, 6656292], [6662928, 6663079], [6668314, 6674496]], "strand": 1, "transcript": "NM_001324322", "txend": 6674496, "txstart": 6633552}, {"cdsend": 6668381, "cdsstart": 6645348, "chr": "5", "position": [[6633552, 6633982], [6644920, 6645422], [6651954, 6652121], [6656190, 6656292], [6662928, 6663079], [6668314, 6674496]], "strand": 1, "transcript": "NM_001324323", "txend": 6674496, "txstart": 6633552}, {"cdsend": 6674496, "cdsstart": 6674496, "chr": "5", "position": [[6633552, 6633982], [6651954, 6652121], [6653559, 6653749], [6656190, 6656292], [6662928, 6663079], [6668314, 6674496]], "strand": 1, "transcript": "NR_136739", "txend": 6674496, "txstart": 6633552}], "generif": [{"pubmed": 11903314, "text": "role in blood pressure"}, {"pubmed": 11948017, "text": "examination of differential methylation of isoenzyme genes in lymphocytes"}, {"pubmed": 12670724, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12670724, "text": "polymorphisms of SRD5A1 and SRD5A2 genes may not be directly associated with the development of baldness or generation of different clinical phenotypes."}, {"pubmed": 12738739, "text": "Loss of 5alpha-reductase type I expression is associated with metastatic prostate cancer"}, {"pubmed": 14671189, "text": "Changes in 5alpha-reductase, 11beta-HSD1, and 20alpha/beta-HSD enzyme activities observed in polycystic ovary syndrome may contribute to increased production of cortisol and androgens."}, {"pubmed": 14739525, "text": "Mutant SRD5A1 isoenzyme does not seem to play a crucial role in the development of hypospadias."}, {"pubmed": 14997014, "text": "The direct challenge of beta-adrenergic agonists to glioma cells resulted in the rapid and transient elevation of 5alpha-R mRNA levels through the activation of the cyclic AMP (cAMP)/protein kinase A-mediated signaling pathway."}, {"pubmed": 15004407, "text": "Glucocorticoids and androgens differentially regulate 5alphaR1 mRNA in the rat liver. Regulation of 5alphaR1 gene is primarily at the post-transcriptional level."}, {"pubmed": 15136785, "text": "Candidate gene for benign prostatic hyperplasia."}, {"pubmed": 15136785, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15212687, "text": "Expression of SRD5A1 (5alphaR1) and SRD5A2 (5alphaR2) is elevated, and expression of AKR1C1 (20alpha-HSO), AKR1C2 (3alpha-HSO3) and AKR1C3 (3alpha-HSO2) is reduced in tumorous as compared to normal breast tissue."}, {"pubmed": 15538746, "text": "5alpha-reductase type 1 (5alphaR1) immunostaining is increased and 5alpha-reductase type 2(5alphaR2) immunostaining is decreased during development of prostate cancer and there is increased expression of both in recurrent and metastatic cancers"}, {"pubmed": 15543614, "text": "Serenoa repens inhibits this enzyme in the prostate, but does not suppress prostate-specific antigen secretion in prostate cancer."}, {"pubmed": 15792368, "text": "5alpha-reductase is expresed in human embryonic kidney cell line HEK293"}, {"pubmed": 15862960, "text": "The expression of 5alpha-reductase type I mRNA was not regulated by calcitriol in a prostate tumor cell line."}, {"pubmed": 15941927, "text": "SRD5A1 is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of SRD5A2-deficient males."}, {"pubmed": 16100771, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16155734, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16818707, "text": "The SRD5A1 mRNA expression is 2-fold lower than SRD5A2 in normal rat."}, {"pubmed": 16849416, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17066438, "text": "These results suggest that intratumoral 5 alpha-dihydrotestosterone concentration is mainly determined by 5alphaRed1 and aromatase in breast carcinoma tissues."}, {"pubmed": 17218734, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18008328, "text": "Both 5-alpha-reductase I and II are expressed in normal human prostate stromal and epithelial cells. Only 5-alpha-reductase isoenzymes of prostate epithelium are modulated by oxytocin."}, {"pubmed": 18215136, "text": "Hepatocyte growth factor stimulates 5alpha-R1 expression through up-regulation of the transcription factor early growth response 1"}, {"pubmed": 18258185, "text": "Our results demonstrate that the 5alphaR activities of either bDPCs or sDPCs are stronger than that of dermal fibroblasts, despite the fact that the major steroidogenic activity is attributed to 17beta-HSD rather than 5alphaR among the three cell types."}, {"pubmed": 18422030, "text": "Testosterone 5-alpha-Reductase deficiency is associated with gender identity"}, {"pubmed": 18483391, "text": "the SRD5A2 V89L VV genotype interacts with VDR FokI TT/CT genotypes in non-Hispanic White men and VDR CDX2 GG genotypes in Hispanic White men to increase the risk for prostate cancer."}, {"pubmed": 18633104, "text": "Enhanced 5alphaR activity in both sexes is associated with insulin resistance but not body composition"}, {"pubmed": 18636124, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19246976, "text": "A decreased local enzymatic conversion of testosterone may contribute to PAD genetic susceptibility."}, {"pubmed": 19246976, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19383266, "text": "Report changes in human placental 5alpha-reductase isoenzyme expression with advancing gestation: effects of fetal sex and glucocorticoid exposure."}, {"pubmed": 19574343, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19598235, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19846565, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19886072, "text": "hyperandrogenemia is associated with high levels of expression of 5-alpha reductase type 1 and, to a less extent, of type 2 isoenzyme in pubian skin cultured fibroblasts"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20056642, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20056642, "text": "We investigated associations between single nucleotide polymorphisms in genes HSD3B1, SRD5A1/2, and AKR1C2 and prostate cancer risk"}, {"pubmed": 20086173, "text": "Data indicate that enzymes CYP17A1 and HSD3B1 showed low expression, while AKR1C3 and SRD5A1 were abundantly expressed."}, {"pubmed": 20200332, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20214802, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20519274, "text": "High nuclear SRD5A1 expression is associated with higher prostate cancer stage."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634197, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20672519, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20800085, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21323680, "text": "Evidence of association of two alleles for alcohol dependence (AD) is found in SRD5A1 and AKR1C3, mediating a protective effect of the minor allele at each AD marker based on the genotype of the second marker."}, {"pubmed": 21447938, "text": "Pitfalls in the diagnosis of 5alpha-reductase type 2 deficiency during early infancy."}, {"pubmed": 21530059, "text": "Single nucleotide polymorphisms in the two isoforms of 5alpha-reductase, SRD5A1 and SRD5A2, are associated with lean patients with polycystic ovary syndrome."}, {"pubmed": 21676395, "text": "A statistically significant reduction of SRD5A1, SRD5A2, and CYP19A gene expression was found in the dermal papillae cells and peripheral blood mononuclear cells in idiopathic hirsutism."}, {"pubmed": 21715084, "text": "Show positive associations of several SRD5A1 and SRD5A2 variations as independent predictors of biochemical recurrence after radical prostatectomy."}, {"pubmed": 21795608, "text": "the dominant route of Dihydrotestosterone synthesis in castration-resistant prostate cancer bypasses testosterone, and instead requires 5alpha-reduction of androstenedione by SRD5A1 to 5alpha-androstanedione, which is then converted to DHT"}, {"pubmed": 21947678, "text": "Postmenopausal breast cancer risk associated with combined therapy may be modified by genetic variation in SRD5A1"}, {"pubmed": 22194926, "text": "The different expression levels of 5alpha-reductase isoenzymes may confer response or resistance to 5alpha-reductase inhibitors."}, {"pubmed": 22273344, "text": "Ten percent of cases and 44% of controls had the cytosine/cytosine (C/C) genotype for the SRD5A1 SNP, rs501999 indicating that this genotype may protect women against severe premenstrual symptoms."}, {"pubmed": 22509838, "text": "Based on a limited selection of gene variants, no involvement of SRD5A1, SRD5A2, ESR1, ESR2 or PGR in female pattern hair loss is evident."}, {"pubmed": 23183084, "text": "Different effects were seen for progesterone, which significantly decreased SRD5A1 protein levels."}, {"pubmed": 23499746, "text": "SRD5A1 and SRD5A2 single nucleotide polymorphisms are significantly associated with the clinical characteristics of benign prostatic hyperplasia and the efficacy of benign prostatic hyperplasia treatment."}, {"pubmed": 24244276, "text": "Significantly higher levels of SRD5A1, AKR1C2, AKR1C3, and HSD17B10 mRNA were however found in bone metastases than in non-malignant and/or malignant prostate tissue"}, {"pubmed": 24277450, "text": "SRD5A1 rs166050C risk variant was associated with greater prostatic exposure to androsterone"}, {"pubmed": 24986533, "text": "Increased 5alphaR activity and glucocorticoid secretion rate over time are linked with the development of metabolic disease, and may represent targets for therapeutic intervention."}, {"pubmed": 25463305, "text": "In model cell lines of endometrial cancer, AKR1C2 and SRD5A1 have crucial roles in progesterone metabolism."}, {"pubmed": 25475427, "text": "Results show that 5alpha-reductase type 1 was associated with intratumoral dihydrotestosterone concentrations and is an independent prognostic factor in endometrioid endometrial adenocarcinoma."}, {"pubmed": 25850410, "text": "study found SRD5A enzyme is present in spermatozoa and that its cellular content is lowered in sperm samples from varicocele patients compared to healthy subjects"}, {"pubmed": 25960412, "text": "A total of 2 SNPs in SRD5A1-rs3822430 and rs1691053-were associated with prostate-specific antigen level at diagnosis."}, {"pubmed": 26174685, "text": "the genotypic distribution of 22 single nucleotide polymorphisms in SRD5A1 and SRD5A2 in a set of Spanish prostate cancer patients, were evaluated."}, {"pubmed": 26243543, "text": "SRD5A1 small-interfering RNA knockdown led to significant increase in progesterone receptor-B nuclear import, ectopic, whereas SRD5A1 overexpression resulted in remarkable inhibition of nuclear progesterone receptor-B in P4-treated cells. Repression of SRD5A1 activated progesterone receptor-B responsive gene, whereas overexpression of SRD5A1 possessed an inhibitory effect."}, {"pubmed": 26855069, "text": "Although 4-dione is the main source of 5alpha-dihydrotestosterone in human preadipocytes, production of this steroid by 5 alpha-reductase isoenzymes (SRD5A1, 2 and 3) mediates the inhibitory effect of both 4-dione and testosterone on preadipocyte differentiation."}, {"pubmed": 28347315, "text": "Studies indicate that enhanced 5alpha-reductase activity in subjects with polycystic ovary syndrome (PCOS) was associated with insulin resistance (IR) rather than obesity."}, {"pubmed": 28947209, "text": "we demonstrated that AR, 5alphaR1 and 5alphaR2 immunoreactivity in bladder urothelial carcinoma cells significantly decreased with advanced tumor grade."}, {"pubmed": 29084161, "text": "The study described in this article shows that selected SRD5A1 and SRD5A2 polymorphisms can alter the levels of metabolic and hormonal parameters in patients with BPH. Special attention should be paid to the SDR5A2 rs12470143 polymorphism, which is associated with a change in lipid profile, as well as with the inheritance and incidence rate of MetS among these patients."}, {"pubmed": 29187470, "text": "Findings suggest that 5alpha-reductases (5-AR) isoenzymes could be explored as a therapeutic target for urothelial bladder cancer (UBC) with 5alpha-reductase inhibitors (5-ARI)."}, {"pubmed": 31199473, "text": "Deficiency or inhibition of 5alphaR1 predisposes men and mice to insulin resistance and fatty liver."}, {"pubmed": 31870594, "text": "Associations of SRD5A1 gene variants and testosterone with dysglycemia: Henan Rural Cohort study."}, {"pubmed": 32716491, "text": "Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5alpha-Reductases."}, {"pubmed": 33627630, "text": "Suppression of steroid 5alpha-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma."}, {"pubmed": 34764940, "text": "Steroid Metabolism in Children and Adolescents With Obesity and Insulin Resistance: Altered SRD5A and 20alpha/20betaHSD Activity."}, {"pubmed": 34885733, "text": "Treatment of Benign Prostatic Hyperplasia by Natural Drugs."}, {"pubmed": 34996447, "text": "Epigenetic regulation of 5alpha reductase-1 underlies adaptive plasticity of reproductive function and pubertal timing."}], "genomic_pos": {"chr": "5", "end": 6676539, "ensemblgene": "ENSG00000145545", "start": 6633290, "strand": 1}, "genomic_pos_hg19": {"chr": "5", "end": 6669675, "start": 6633456, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001655", "qualifier": "involved_in", "term": "urogenital system development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001889", "qualifier": "involved_in", "term": "liver development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006694", "qualifier": "involved_in", "term": "steroid biosynthetic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006702", "qualifier": "involved_in", "term": "androgen biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006710", "qualifier": "involved_in", "term": "androgen catabolic process"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007530", "pubmed": 1686016, "qualifier": "involved_in", "term": "sex determination"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008584", "qualifier": "involved_in", "term": "male gonad development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009267", "qualifier": "involved_in", "term": "cellular response to starvation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009410", "qualifier": "involved_in", "term": "response to xenobiotic stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014850", "qualifier": "involved_in", "term": "response to muscle activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016101", "qualifier": "involved_in", "term": "diterpenoid metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021510", "qualifier": "involved_in", "term": "spinal cord development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021766", "qualifier": "involved_in", "term": "hippocampus development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021794", "qualifier": "involved_in", "term": "thalamus development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021854", "qualifier": "involved_in", "term": "hypothalamus development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021983", "qualifier": "involved_in", "term": "pituitary gland development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021987", "qualifier": "involved_in", "term": "cerebral cortex development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030539", "qualifier": "involved_in", "term": "male genitalia development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030540", "qualifier": "involved_in", "term": "female genitalia development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032354", "qualifier": "involved_in", "term": "response to follicle-stimulating hormone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032869", "qualifier": "involved_in", "term": "cellular response to insulin stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042428", "qualifier": "involved_in", "term": "serotonin metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042448", "qualifier": "involved_in", "term": "progesterone metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043627", "qualifier": "involved_in", "term": "response to estrogen"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060348", "qualifier": "involved_in", "term": "bone development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060416", "qualifier": "involved_in", "term": "response to growth hormone"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060992", "qualifier": "involved_in", "term": "response to fungicide"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071320", "qualifier": "involved_in", "term": "cellular response to cAMP"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071363", "qualifier": "involved_in", "term": "cellular response to growth factor stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071392", "qualifier": "involved_in", "term": "cellular response to estradiol stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071394", "qualifier": "involved_in", "term": "cellular response to testosterone stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071549", "qualifier": "involved_in", "term": "cellular response to dexamethasone stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071872", "qualifier": "involved_in", "term": "cellular response to epinephrine stimulus"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0048471", "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0070852", "qualifier": "located_in", "term": "cell body fiber"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003865", "qualifier": "enables", "term": "3-oxo-5-alpha-steroid 4-dehydrogenase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003865", "pubmed": 17986282, "qualifier": "enables", "term": "3-oxo-5-alpha-steroid 4-dehydrogenase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003865", "qualifier": "enables", "term": "3-oxo-5-alpha-steroid 4-dehydrogenase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0009055", "pubmed": 1686016, "qualifier": "enables", "term": "electron transfer activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0033218", "qualifier": "enables", "term": "amide binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0047751", "qualifier": "enables", "term": "3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0070402", "qualifier": "enables", "term": "NADPH binding"}]}, "homologene": {"genes": [[3702, 818383], [4530, 4324809], [4530, 9272051], [4896, 2543655], [7955, 767715], [8364, 448586], [9031, 770453], [9544, 695103], [9598, 743740], [9606, 6715], [9615, 403716], [9913, 614612], [10090, 78925], [10116, 24950], [318829, 2677199]], "id": 37426}, "interpro": [{"desc": "3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal", "id": "IPR001104", "short_desc": "3-oxo-5_a-steroid_4-DH_C"}, {"desc": "3-oxo-5-alpha-steroid 4-dehydrogenase", "id": "IPR016636", "short_desc": "3-oxo-5-alpha-steroid_4-DH"}, {"desc": "3-oxo-5-alpha-steroid 4-dehydrogenase/very-long-chain enoyl-CoA reductase", "id": "IPR039357", "short_desc": "SRD5A/TECR"}], "ipi": ["IPI00032233", "IPI00921801", "IPI00922241", "IPI00967071", "IPI00967636"], "map_location": "5p15.31", "name": "steroid 5 alpha-reductase 1", "other_names": ["3-oxo-5-alpha-steroid 4-dehydrogenase 1", "SR type 1", "steroid 5-alpha-reductase type I", "steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)"], "pantherdb": {"HGNC": "11284", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "98400", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 10090, "uniprot_kb": "Q68FF9"}, {"RGD": "3757", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 10116, "uniprot_kb": "P24008"}, {"Ensembl": "ENSGALG00000013063", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 9031, "uniprot_kb": "F1NJM2"}, {"ZFIN": "ZDB-GENE-060929-938", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 7955, "uniprot_kb": "A5PMI4"}, {"WormBase": "WBGene00014241", "ortholog_type": "O", "panther_family": "PTHR10556", "taxid": 6239, "uniprot_kb": "Q23431"}, {"WormBase": "WBGene00008959", "ortholog_type": "O", "panther_family": "PTHR10556", "taxid": 6239, "uniprot_kb": "Q19605"}, {"WormBase": "WBGene00009635", "ortholog_type": "LDO", "panther_family": "PTHR10556", "taxid": 6239, "uniprot_kb": "Q20344"}], "uniprot_kb": "P18405"}, "pathway": {"humancyc": [{"id": "PWY-7305", "name": "superpathway of steroid hormone biosynthesis"}, {"id": "PWY-7455", "name": "allopregnanolone biosynthesis"}, {"id": "PWY66-378", "name": "androgen biosynthesis"}], "kegg": {"id": "hsa00140", "name": "Steroid hormone biosynthesis - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-193048", "name": "Androgen biosynthesis"}, {"id": "R-HSA-196071", "name": "Metabolism of steroid hormones"}, {"id": "R-HSA-556833", "name": "Metabolism of lipids"}, {"id": "R-HSA-8957322", "name": "Metabolism of steroids"}], "smpdb": [{"id": "SMP00068", "name": "Androgen and Estrogen Metabolism"}, {"id": "SMP00356", "name": "17-Beta Hydroxysteroid Dehydrogenase III Deficiency"}, {"id": "SMP00565", "name": "Aromatase deficiency"}], "wikipathways": {"id": "WP4842", "name": "Mammalian disorder of sexual development"}}, "pfam": "PF02544", "pharmgkb": "PA36112", "pharos": {"target_id": 14756, "tdl": "Tclin"}, "pir": "A55274", "prosite": "PS50244", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF256691", "relationship": "is"}, {"id": "GNF256692", "relationship": "is"}, {"id": "GNF256693", "relationship": "is"}, {"id": "GNF256694", "relationship": "is"}, {"id": "GNF256695", "relationship": "is"}, {"id": "GNF256696", "relationship": "is"}, {"id": "GNF256697", "relationship": "is"}, {"id": "GNF256698", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161186", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF030920", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF013956", "relationship": "is"}, {"id": "GNF013957", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF233721", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF101802", "relationship": "is"}, {"id": "GNF141457", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000005.10", "NC_060929.1"], "protein": ["NP_001038.1", "NP_001311251.1", "NP_001311252.1"], "rna": ["NM_001047.4", "NM_001324322.2", "NM_001324323.2", "NR_136739.2"], "translation": [{"protein": "NP_001311252.1", "rna": "NM_001324323.2"}, {"protein": "NP_001038.1", "rna": "NM_001047.4"}, {"protein": "NP_001311251.1", "rna": "NM_001324322.2"}]}, "reporter": {"HG-U133_Plus_2": ["204675_at", "210959_s_at", "211056_s_at"], "HG-U95Av2": "589_at", "HTA-2_0": "TC05000044.hg.1", "HuEx-1_0": ["2800477", "3993057"], "HuGene-1_1": "8104369", "HuGene-2_1": "16982947"}, "summary": "Steroid 5-alpha-reductase (EC 1.3.99.5) catalyzes the conversion of testosterone into the more potent androgen, dihydrotestosterone (DHT). Also see SRD5A2 (MIM 607306).[supplied by OMIM, Mar 2008].", "symbol": "SRD5A1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420395"}, "unigene": "Hs.552", "uniprot": {"Swiss-Prot": "P18405", "TrEMBL": ["D6RG03", "B7Z4D8", "A0AAA9YHF0", "D6RDL6"]}, "wikipedia": {"url_stub": "SRD5A1"}}